These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 35043376

  • 1. Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.
    Wu P, Dong Y, Chen J, Guan T, Cao B, Zhang Y, Qi Y, Guan Z, Wang Y.
    Neurotox Res; 2022 Feb; 40(1):286-297. PubMed ID: 35043376
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity.
    Wang Y, Chen C, Huang W, Huang M, Wang J, Chen X, Ye Q.
    Aging (Albany NY); 2019 Oct 21; 11(20):8937-8950. PubMed ID: 31634150
    [Abstract] [Full Text] [Related]

  • 3. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
    Jhuo CF, Chen CJ, Tzen JTC, Chen WY.
    Environ Toxicol; 2024 Jul 21; 39(7):4022-4034. PubMed ID: 38622810
    [Abstract] [Full Text] [Related]

  • 4. Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.
    Clark J, Silvaggi JM, Kiselak T, Zheng K, Clore EL, Dai Y, Bass CE, Simon DK.
    PLoS One; 2012 Jul 21; 7(11):e48925. PubMed ID: 23145024
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
    Dong Y, Qi Y, Chen J, Han S, Su W, Ma X, Yu Y, Wang Y.
    Mol Neurobiol; 2024 Oct 21; 61(10):7534-7548. PubMed ID: 38409641
    [Abstract] [Full Text] [Related]

  • 6. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Mudò G, Mäkelä J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O, Mälkiä A, Bonomo A, Kairisalo M, Aguirre JA, Korhonen L, Belluardo N, Lindholm D.
    Cell Mol Life Sci; 2012 Apr 21; 69(7):1153-65. PubMed ID: 21984601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
    Sivasubramanian M, Kanagaraj N, Dheen ST, Tay SS.
    Neuroscience; 2015 Apr 02; 290():636-48. PubMed ID: 25637806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C.
    Eur J Pharmacol; 2017 Oct 05; 812():82-90. PubMed ID: 28666800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.